Jinwon Life Sciences Signs Plasmid DNA Supply Contract Worth $3.6 Million
Jinwon Life Sciences announced on the 24th that it has signed a plasmid DNA pharmaceutical supply contract worth 3.6 million USD with a US biotech company.
A company representative explained, "The name of the contracting party cannot be disclosed due to a confidentiality clause in the contract, and when converted to Korean won, the contract amount is approximately 5 billion KRW."
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- 59% of Americans Say "U.S. Prime Has Already Passed"... 44% Pessimistic About Next 50 Years
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Park Young-geun, CEO of Jinwon Life Sciences, stated, "As the development of cell and gene therapies expands, the demand for plasmid DNA is increasing, so based on the high-quality plasmid DNA supply capabilities of our subsidiary VGXI, we expect continuous orders."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
